HCM
Howland Capital Management Portfolio holdings
AUM
$2.45B
This Quarter Return
+6.01%
1 Year Return
+18.92%
3 Year Return
+69.21%
5 Year Return
+110.29%
10 Year Return
+257.66%
AUM
$1.41B
AUM Growth
+$1.41B
(+6.7%)
Cap. Flow
+$18.3M
Cap. Flow
% of AUM
1.3%
Top 10 Holdings %
Top 10 Hldgs %
32.61%
Holding
228
New
18
Increased
93
Reduced
81
Closed
4
Top Buys
| 1 |
Vanguard FTSE All-World ex-US ETF
VEU
|
$8.92M |
| 2 |
Bristol-Myers Squibb
BMY
|
$7.52M |
| 3 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
$5.61M |
| 4 |
PIMCO Enhanced Low Duration Active Exchange-Traded Fund
LDUR
|
$4.79M |
| 5 |
UGI
UGI
|
$4.09M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$12.9M |
| 2 |
Microsoft
MSFT
|
$4.79M |
| 3 |
American Tower
AMT
|
$3.17M |
| 4 |
Thermo Fisher Scientific
TMO
|
$1.95M |
| 5 |
Ecolab
ECL
|
$1.7M |
Sector Composition
| 1 | Healthcare | 15.8% |
| 2 | Technology | 11.96% |
| 3 | Financials | 11.66% |
| 4 | Consumer Discretionary | 6.87% |
| 5 | Industrials | 5.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
DuPont de Nemours
DD
$32.2B
| $1.33M | 0.09% |
20,740
-8,385
| -29% | -$539K |
|
102
AbbVie
ABBV
$372B
| $1.31M | 0.09% |
14,819
+379
| +3% | +$33.6K |
|
103
Snap-on
SNA
$17B
| $1.3M | 0.09% |
7,700
-230
| -3% | -$39K |
|
104
IBM
IBM
$227B
| $1.28M | 0.09% |
9,544
-1,220
| -11% | -$163K |
|
105
iShares Core High Dividend ETF
HDV
$11.7B
| $1.28M | 0.09% |
13,000
| – | – |
|
106
Becton Dickinson
BDX
$55.3B
| $1.23M | 0.09% |
4,524
+11
| +0.2% | +$2.99K |
|
107
Core Laboratories
CLB
$540M
| $1.17M | 0.08% |
31,116
+4,600
| +17% | +$173K |
|
108
Dow Inc
DOW
$17.5B
| $1.13M | 0.08% |
20,662
-9,485
| -31% | -$519K |
|
|
RTN
109
DELISTED
Raytheon Company
RTN
| $1.13M | 0.08% |
5,123
-7
| -0.1% | -$1.54K |
|
110
Vanguard Mid-Cap Value ETF
VOE
$18.8B
| $1.08M | 0.08% |
9,020
| – | – |
|
111
Meta Platforms (Facebook)
META
$1.86T
| $1.07M | 0.08% |
5,203
+84
| +2% | +$17.2K |
|
112
Yum China
YUMC
$16.4B
| $1.02M | 0.07% |
21,247
-17
| -0.1% | -$816 |
|
113
Intuitive Surgical
ISRG
$170B
| $1.01M | 0.07% |
1,703
+5
| +0.3% | +$2.96K |
|
114
Marsh & McLennan
MMC
$101B
| $1.01M | 0.07% |
9,020
+211
| +2% | +$23.5K |
|
115
AstraZeneca
AZN
$248B
| $981K | 0.07% |
19,668
-1,590
| -7% | -$79.3K |
|
116
Illumina
ILMN
$15.8B
| $977K | 0.07% |
2,945
-247
| -8% | -$81.9K |
|
117
Brown-Forman Class A
BF.A
$14.3B
| $942K | 0.07% |
15,000
| – | – |
|
118
Emerson Electric
EMR
$74.3B
| $938K | 0.07% |
12,306
+693
| +6% | +$52.8K |
|
119
NeoGenomics
NEO
$1.13B
| $917K | 0.07% |
31,337
| – | – |
|
120
AT&T
T
$209B
| $900K | 0.06% |
23,030
-5,221
| -18% | -$204K |
|
121
Avery Dennison
AVY
$13.4B
| $883K | 0.06% |
6,750
| – | – |
|
122
Verizon
VZ
$186B
| $860K | 0.06% |
14,005
+195
| +1% | +$12K |
|
|
123
Brown-Forman Class B
BF.B
$14.2B
| $845K | 0.06% |
12,500
| – | – |
|
124
Air Products & Chemicals
APD
$65.5B
| $835K | 0.06% |
3,555
+154
| +5% | +$36.2K |
|
125
General Mills
GIS
$26.4B
| $817K | 0.06% |
15,252
-1,000
| -6% | -$53.6K |
|